The University of Alabama at Birmingham (UAB) faculty, staff and administration have hit another institutional milestone for the first time in its 50-year history—exceeding over $600 million in research funding awards. Among all American public and private institutions, UAB ranks in the top 20 in clinical trial funding, which indicates the university’s clinical trial engine is large and industry recognizes the value UAB provides.
At an official total of $602,024,372 in research grants for the 12 month period ending Sept. 30, 2019, the figure represents an extraordinary increase of $75 million in funding over one year—a 14.2% increase and a second consecutive year of double-digit growth.
UAB year-over-year funding from the National Institutes of Health increased by $38 million from fiscal year 2018-19, or 11.8 percent—another remarkable achievement considering the NIH’s overall funding increased by 5 percent.
Funding from the Department of Defense to UAB also saw a dramatic increase, climbing by more than $7 million, or 63 percent.
UAB’s industry funding for clinical trials jumped by $22 million, or 42 percent, from 2017-18. UAB now ranks eighth among all public universities in the United States in all clinical trial expenditures and sixth among public universities for non-federal clinical trial expenditures. Among all United States public and private institutions, UAB ranks in the top 20 in clinical trial funding, which indicates the university’s clinical trial engine is large and industry recognizes the value UAB provides.
“This record amount in awards is the continuation of the most successful five-year epoch of research funding in UAB history,” said Ray L. Watts, UAB president. “Last year, we had a record $527 million in awards, and we immediately set the bar even higher. Through strong collaboration and partnership—around campus, throughout our community and state, and with our Board—we continue setting and exceeding ambitious goals in research and all pillars of our mission. I could not be prouder of the work of our faculty, staff and students in advancing a research enterprise that is among the most competitive in the nation and around the globe.”